Home

Veritex Holdings, Inc. - Common Stock (VBTX)

21.34
-0.99 (-4.43%)
NASDAQ · Last Trade: Apr 4th, 10:11 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
4 Analysts Assess Veritex Holdings: What You Need To Knowbenzinga.com
Via Benzinga · March 17, 2025
Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · February 3, 2025
Insights into Veritex Holdings Q4 Earningsbenzinga.com
Via Benzinga · January 28, 2025
What Analysts Are Saying About Veritex Holdings Stockbenzinga.com
Via Benzinga · October 24, 2024
What to Expect from Veritex Holdings's Earningsbenzinga.com
Via Benzinga · October 21, 2024
Forecasting The Future: 5 Analyst Projections For Veritex Holdingsbenzinga.com
Via Benzinga · September 17, 2024
Forecasting The Future: 4 Analyst Projections For Veritex Holdingsbenzinga.com
Via Benzinga · August 28, 2024
Expert Outlook: Veritex Holdings Through The Eyes Of 4 Analystsbenzinga.com
Via Benzinga · April 1, 2024
Veritex Holdings: Q4 Earnings Insightsbenzinga.com
Via Benzinga · January 23, 2024
Earnings Scheduled For January 28, 2025benzinga.com
Via Benzinga · January 28, 2025
VBTX Stock Earnings: Veritex Holdings Misses EPS, Misses Revenue for Q2 2024investorplace.com
VBTX stock results show that Veritex Holdings missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 23, 2024
Veritex Holdings's Earnings: A Previewbenzinga.com
Via Benzinga · January 22, 2024
Earnings Outlook For Veritex Holdingsbenzinga.com
Via Benzinga · October 23, 2023
Preview: Veritex Holdings's Earningsbenzinga.com
Via Benzinga · July 24, 2023
Preview: Veritex Holdings's Earningsbenzinga.com
Via Benzinga · April 24, 2023
VBTX Stock Earnings: Veritex Holdings Misses EPS, Misses Revenue for Q1 2024investorplace.com
VBTX stock results show that Veritex Holdings missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · April 23, 2024
Banks With High Commercial Real Estate Loan Exposure In Regulatory Spotlight: Valley National Bancorp And 15 Others To Watchbenzinga.com
US banks with large CRE loan portfolios face increased regulatory scrutiny, but NYCB stands out with steady growth despite exceeding threshold.
Via Benzinga · February 15, 2024
7 Sleeper Stocks Primed to Pack a Surprising Punchinvestorplace.com
Although sleeper stocks to buy may seem incredibly boring at first, these analyst-backed ideas could change your mind.
Via InvestorPlace · September 13, 2023
The 7 Most Undervalued Bank Stocks to Buy in September 2023investorplace.com
Trading at low earnings multiples, and at big discounts to book value, these are the most undervalued bank stocks.
Via InvestorPlace · September 12, 2023
Earnings Scheduled For April 23, 2024benzinga.com
Companies Reporting Before The Bell • RTX (NYSE:RTX) is expected to report quarterly earnings at $1.23 per share on revenue of $18.41 billion.
Via Benzinga · April 23, 2024
Earnings Scheduled For January 23, 2024benzinga.com
Companies Reporting Before The Bell • Webster Finl (NYSE:WBS) is estimated to report quarterly earnings at $1.46 per share on revenue of $603.11 million.
Via Benzinga · January 23, 2024
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023benzinga.com
Via Benzinga · July 5, 2023
Stocks That Hit 52-Week Lows On Thursdaybenzinga.com
  On Thursday, 498 companies reached new 52-week lows.
Via Benzinga · May 4, 2023
7 Value Stocks to Buy for 100% Returnsinvestorplace.com
These aren’t just your garden-variety value stocks to buy. Rather, if you can handle the risk, these ideas could double in price.
Via InvestorPlace · April 16, 2023
Why RAPT Therapeutics Shares Are Trading Lower By Over 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com
Gainers Ainos, Inc. (NASDAQ: AIMD) shares jumped 69.3% to $1.27 after the company announced it signed a Memorandum of Understanding with Merdury Biopharmaceutical to jointly explore and develop a strategic business relationship.
Via Benzinga · March 14, 2023